The swab and viral transport medium market for United Kingdom will increase to USD 515.2 million cumulatively by the end of the next ten years. However, this industry will continue at a growth pace of 2.2% per annum over the said ten years. Thus, in the year 2025, this market is going to be worth USD 414.4 million. Therefore, this goes to indicate a CAGR of 2.5% of the market through the five years of forecast 2025 to 2035 period.
| Attributes | Values |
|---|---|
| Estimated Industry Size 2025 | USD 414.4 million |
| Projected Value 2035 | USD 515.2 million |
| Value-based CAGR from 2025 to 2035 | 2.2% |
This particular market of swab and viral transport medium for the near term will grow significantly in United Kingdom, facilitated by solid public health initiatives. United Kingdom is one of the largest contributor in the expansion of the sector by 2025 in the European market. The market is expected to gain a steady CAGR of 2.2% till 2035, and the opportunity reflects a sustainable growth and investment future.
The increasing infectious diseases, mainly respiratory infections such as RSV and influenza, fuel the UK swab and viral transport medium market. When these infectious diseases are prevalent, the collection and transportation of samples become vital to ensure proper detection, which has further led to steady growth of the market since the healthcare sector relies on good diagnostics for sound outcomes.
Explore FMI!
Book a free demo
The table below offers a detailed comparative assessment of the changes in the compound annual growth rate (CAGR) over six months for the base year (2023) and the current year (2024) specifically for the United Kingdom swab and viral transport medium market.
This semi-annual analysis highlights crucial shifts in market dynamics and outlines revenue realization patterns, providing stakeholders with a more precise understanding of the growth trajectory within the year. The first half of the year H1, covers January to June, while the second half, H2, spans July to December.
H1 Indicates from January to June, H2 Indicates from July to December
The swab and viral transport medium sector of the United Kingdom market is to grow at 2.5% CAGR in the first half of 2023; however, that growth rate increases to 2.7% in the same year's second half. During 2024, the rate is expected to decrease slightly at 2.2% for H1, but it's supposed to climb up to 3.0% for H2. This pattern shows a decline of 32 basis points from the first half of 2023 to the first half of 2024, while in the second half of 2024, it is raised by 24 basis points compared to the second half of 2023.
These figures represent a dynamic and fast-changing United Kingdom swab and viral transport medium market, influenced by government-funded testing programs, advanced diagnostic infrastructure, growing focus on pandemic preparedness, and others.
This semestral breakup is crucial to businesses that chart their strategies, taking into consideration the growth trends and navigating market complexities.
| Date | Development/M&A Activity & Details |
|---|---|
| 2025 | Launch: Thermo Fisher Scientific drive growth by introducing innovative swabs and viral transport mediums with enhanced features, such as improved sample preservation and faster diagnostic compatibility. Strategic product launches target unmet healthcare needs, expanding market share and brand visibility. |
| 2024 | Expansion: McKesson company strengthen their presence by entering new markets, building robust distribution networks, and forming partnerships with healthcare providers to cater to growing demand for diagnostic solutions across diverse regions. |
| 2024 | Government Support: By endorsing widespread testing programs and pandemic preparedness, governments help ensure a steady demand for swabs and viral transport mediums in healthcare systems. |
Government-Funded Testing Programs
The UK’s government-backed diagnostic testing programs, including those for COVID-19 and influenza, drive substantial demand for swabs and viral transport mediums. These public health initiatives ensure the availability of reliable diagnostic tools, supporting the efficient collection and transportation of samples during widespread testing efforts.
Growing Focus on Pandemic Preparedness
High government investment in pandemic preparedness and response measures contributes to increased demand for diagnostic tools. It also ensures rapid and accurate testing during outbreaks, making swabs and VTMs work towards strengthening healthcare systems in being quick and effective in responding to public health emergencies.
% share of Individual categories by Product Type and Application in 2025
Virus Swabs records significant surge in United Kingdom Swab and Viral Transport Medium applications
Virus swabs dominate due to their critical role in accurate sample collection for diagnostic tests. High demand for precision, efficiency, and compatibility with advanced testing methods drives their market leadership.
The varicella-zoster virus segment will likely grow a lot in the market, especially due to an increased demand for accurate diagnostic testing for VZV infections. Varicella-Zoster Virus causes chickenpox and shingles, both of which are highly contagious viral infections requiring prompt diagnosis for proper treatment and management.
The United Kingdom swab and viral transport medium market presents a moderate degree of fragmentation, owing to the presence of both multinational players and regional companies; this drives fierce competition. Multinationals have captured the marketplace with their groundbreaking technology, established infrastructure, and broad customer base.
Local players are similarly taking up valuable market share for their customized approach, especially tailored for niche use such as for field hospitals, emergency response, and remote/underserved rurality areas.
The competitive landscape is more and more dominated by technological progress and the demand for fulfilling different needs of clients. Companies are concentrating on R&D activities to make swab and viral transport medium compact, energy efficient, and cheaper. With the German sustainability agenda, most of the players are now incorporating environment-friendly features into their products.
Add to this the prevalence of partnerships and joint ventures, where companies are co-developing innovative solutions while expanding their market reach. The interplay between the global leaders and the agile regional competitors fosters a culture of constant innovation and adaptability in United Kingdom’ swab and viral transport medium market.
2025 Market share of United Kingdom Swab and Viral Transport Medium suppliers
Note: above chart is indicative in nature
By 2025, the United Kingdom swab and viral transport medium market is expected to grow at a CAGR of 2.2%.
By 2035, the sales value of the United Kingdom swab and viral transport medium industry is expected to reach United Kingdom is USD 515.2 million.
Key factors propelling the United Kingdom swab and viral transport medium market include rising point-of-care testing adoption, growing focus on pandemic preparedness, ensuring widespread adoption of high-quality swabs and VTMs.
Prominent players in the United Kingdom swab and viral transport medium manufacturing include Becton, Dickinson and Company, McKesson Laboratories, Cardinal Health, Inc., Thermo Fisher Scientific, Quidel Corporation, Copan Diagnostic, Inc., Deltalab, VIRCELL S.L., Titan Biotech, Inc., Medical wire & Equipment (MWE) and Others. These companies are noted for their innovation, extensive product portfolios, and strategic market positioning.
The industry includes various product type such as viral transport medium (tissue culture medium, glycerol transport medium) and virus swabs (nasopharyngeal swabs, deep nasal swabs, combined nasal & throat swabs, culture swabs, vaginal swabs).
Available in application like influenza, respiratory syncytial virus, mumps virus, adenovirus, rhinovirus, herpes simplex virus, varicella-zoster virus and other indication
Cerebral Aneurysm Management Market Insights – Trends & Forecast 2025 to 2035
Chloangiocarcinoma (CCA) Therapeutics Market – Growth & Drug Innovations 2025 to 2035
Chronic Refractory Cough Treatment Market – Growth & Innovations 2025 to 2035
Chronic Granulomatous Disease (CGD) Management Market – Size, Share & Trends 2025 to 2035
Central Pain Syndrome Management Market – Size, Share & Growth 2025 to 2035
Chronic Smell and Flavor Loss Treatment Market – Innovations & Growth 2025 to 2035
United Kingdom Swab and Viral Transport Medium Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
